Transforming biomedical innovations into therapies
To make a meaningful difference in patients’ lives
more about us-
ReCode Therapeutics Announces First Participants Dosed in a Phase 1 Healthy Volunteer Clinical Study of Inhaled mRNA-Based Genetic Medicine, RCT2100, for the Treatment of Cystic Fibrosis
read more -
Intellia Therapeutics and ReCode Therapeutics Announce Strategic Collaboration to Develop Novel Gene Editing Therapies for Cystic Fibrosis
read more -
Kyverna Therapeutics Announces Pricing of Upsized Initial Public Offering
read more
Core Values
patients
Keep front and center in all that we do
integrity
Hold ourselves and our partners to the highest standards
integrity
Hold ourselves and our partners to the highest standards
entrepreneurship
Take initiative to turn ideas into reality
entrepreneurship
Take initiative to turn ideas into reality
boldness
Drive breakthrough science into medicines
boldness
Drive breakthrough science into medicines
humility
Recognize that the best can come from anywhere
humility
Recognize that the best can come from anywhere
collaboration
Partner to create something grander than the parts
collaboration
Partner to create something grander than the parts
flexibility
Embrace each endeavor with an open mind
flexibility
Embrace each endeavor with an open mind